Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > News > Nano Makes Another Delivery

February 15th, 2005

Nano Makes Another Delivery

Abstract:
We recently profiled several nanobio companies that are developing novel and improved drug delivery technologies. On the day that profile was published, nanobio company pSivida Ltd. (Nasdaq: PSDV), working on yet another competing nano-inspired drug delivery technology, listed with the Nasdaq.

Founded in 2000, pSivida is an Australian company with global ambitions, having also listed on the Frankfurt exchange. Europe's largest research organization, QinetiQ, itself majority owned by the U.K. government, is its single largest shareholder, with 17.5% of the company.

Source:
fool.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

pSivida

Related News Press

Investments/IPO's/Splits

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Profiles

Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011

Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011

Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010

Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010

Financial Reports

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014

Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014

Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE